Leong I T, Fernandes B J, Mock D
Department of Oral Pathology, University of Toronto, Ontario, Canada.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Aug;92(2):184-93. doi: 10.1067/moe.2001.116155.
The purpose of this study was to histologically characterize a series of oral non-Hodgkin's lymphomas (NHLs) and to investigate latent and lytic Epstein-Barr virus (EBV) infection in these.
The revised European-American Lymphoma classification system (41) was used to categorize 58 cases of oral NHL, which included 9 immunosuppression-related NHLs. EBV infection was determined by in situ hybridization for Epstein-Barr virus-encoded RNA and by immunohistochemistry for the EBV antigens latency membrane protein, Epstein-Barr nuclear antigen-2 (EBNA2) and Z EBV replication activator protein.
Most tumors were B-cell lymphomas (78%), but the proportion of T-cell lymphomas was surprisingly high (22%). The most common histologic subtypes were diffuse large B-cell lymphomas (45%), peripheral T-cell lymphomas (19%), and follicle center lymphomas (14%). Two thirds of the known immunosuppression-related NHLs were T-cell lymphomas. All of the immunosuppression-related tumors were EBV-infected, whereas the EBV infection rate in the NHLs of the remaining patients presumed to be immunocompetent was only 9%. Most EBV-positive tumors expressed neither of the latent antigens (ie, latency membrane protein and Epstein-Barr nuclear antigen-2), and coexpression of the 2 was observed only in immunosuppressed patients. Z EBV replication activator protein expression, which is indicative of replicative infection, occurred only in immunosuppressed individuals.
Diffuse large B-cell lymphomas were the most common histologic subtype of oral NHLs, but T-cell lymphomas were relatively common and frequently occurred in states of immunosuppression. EBV may play a limited role in the initiation of lymphoma in the immunocompetent patient, but the virus may be of importance in progression of the disease in those patients with more aggressive tumors, as immunosuppression occurs.
本研究旨在对一系列口腔非霍奇金淋巴瘤(NHL)进行组织学特征分析,并调查其中潜伏性和溶解性爱泼斯坦-巴尔病毒(EBV)感染情况。
采用修订后的欧美淋巴瘤分类系统(41)对58例口腔NHL进行分类,其中包括9例与免疫抑制相关的NHL。通过原位杂交检测爱泼斯坦-巴尔病毒编码RNA以及免疫组化检测EBV抗原潜伏膜蛋白、爱泼斯坦-巴尔核抗原2(EBNA2)和Z EBV复制激活蛋白来确定EBV感染情况。
大多数肿瘤为B细胞淋巴瘤(78%),但T细胞淋巴瘤的比例出奇地高(22%)。最常见的组织学亚型为弥漫性大B细胞淋巴瘤(45%)、外周T细胞淋巴瘤(19%)和滤泡中心淋巴瘤(14%)。已知与免疫抑制相关的NHL中三分之二为T细胞淋巴瘤。所有与免疫抑制相关的肿瘤均感染了EBV,而其余推测免疫功能正常患者的NHL中EBV感染率仅为9%。大多数EBV阳性肿瘤均未表达任何一种潜伏抗原(即潜伏膜蛋白和爱泼斯坦-巴尔核抗原2),仅在免疫抑制患者中观察到两者的共表达。Z EBV复制激活蛋白表达提示复制性感染,仅在免疫抑制个体中出现。
弥漫性大B细胞淋巴瘤是口腔NHL最常见的组织学亚型,但T细胞淋巴瘤相对常见且常发生于免疫抑制状态。EBV在免疫功能正常患者淋巴瘤的起始阶段可能起有限作用,但在那些肿瘤侵袭性更强且出现免疫抑制的患者中,该病毒可能在疾病进展中起重要作用。